Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.2B bought by 555 insiders at 344 companies
- $9.7B sold by 672 insiders outside a trading plan
- $4.8B sold by 992 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$161M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Daniel Masters DirectorCSHRCoinShares PLCPlanned sale$926K 182,370 shares at $5.08 0.8% of stakeTraded Sep 16–18 Filed Sep 18
-
Frederick G Thiel CEOMARAMARA Holdings, Inc.Planned sale$315K 27,505 shares at $11.45 0.6% of stakeTraded Sep 17 Filed Sep 18
-
Zabi Nowaid General CounselMARAMARA Holdings, Inc.Planned sale$101K 8,376 shares at $12.10 0.9% of stakeTraded Sep 18 Filed Sep 18
-
Salman Hassan Khan CFOMARAMARA Holdings, Inc.Planned sale$183K 16,000 shares at $11.45 2.8% of stakeTraded Sep 17 Filed Sep 18
-
Kevin K Gordon DirectorPGNYProgyny, Inc.Sale$312K 11,500 shares at $27.12 63% of stakeTraded Sep 10 Filed Sep 18
-
Andrew J. Schwab DirectorSKYESkye Bioscience, Inc.Sale$65K 33,892 shares at $1.91 86% of stakeTraded Sep 16 Filed Sep 18
-
Shantanu Narayen CEOADBEAdobe Inc.Sale$31.3M 125,000 shares at $250.76 34% of stakeTraded Sep 16–17 Filed Sep 18
-
Michael P. Garthwaite VP (Pres., Products Pipelines)KMIKinder Morgan, Inc.Planned sale$48K 1,550 shares at $30.80 3.1% of stakeTraded Sep 16 Filed Sep 18
-
Jeffrey Howie CFOWSMWilliams-Sonoma, Inc.Planned sale$672K 3,045 shares at $220.61 8.2% of stakeTraded Sep 16 Filed Sep 18
-
Lisa Bodensteiner See RemarksSYNASynaptics IncorporatedPlanned sale$31K 334 shares at $92.63 0.4% of stakeTraded Sep 18 Filed Sep 18
-
Laura Alber CEOWSMWilliams-Sonoma, Inc.Planned sale$7.7M 35,000 shares at $221.20 3.9% of stakeTraded Sep 16 Filed Sep 18
-
Esther Song See RemarksSYNASynaptics IncorporatedPlanned sale$5,836 63 shares at $92.63 0.4% of stakeTraded Sep 18 Filed Sep 18
-
Joseph Baratta DirectorBXBlackstone Inc.Sale$12.4M 100,000 shares at $123.80 12% of stakeTraded Sep 18 Filed Sep 18
-
David Victor Wiens CEOTHMInternational Tower Hill Mines LtdBuy$200K 83,682 shares at $2.39 +14% to stakeTraded Sep 16 Filed Sep 18
-
William T Allen DirectorSVVSavers Value Village, Inc.Sale$241K 26,151 shares at $9.22 48% of stakeTraded Sep 16 Filed Sep 18
-
Tomas Navratil Chief Development OfficerGKOSGlaukos CorporationPlanned sale$243K 1,457 shares at $166.92 2% of stakeTraded Sep 16 Filed Sep 18
-
D Jonathan Merriman DirectorPODCPodcastOne, Inc.Buy$18K 7,700 shares at $2.30 +2.2% to stakeTraded Sep 16 Filed Sep 18
-
Anthony Mathew Eisen DirectorXYZBlock, Inc.Planned sale$1.4M 18,000 shares at $77.63 1.3% of stakeTraded Sep 16–18 Filed Sep 18
-
Cornelius B Prior Jr. 10% ownerATNIATN International, Inc.Sale$308K 9,867 shares at $31.19 33% of stakeTraded Aug 7–21 Filed Sep 18
-
Michael Schmertzler DirectorPTCTPTC Therapeutics, Inc.Planned sale$1.3M 20,000 shares at $67.49 1.5% of stakeTraded Sep 16–17 Filed Sep 18
-
Tami Rosen DirectorPGYPagaya Technologies Ltd.Planned sale$173K 8,504 shares at $20.38 36% of stakeTraded Sep 18 Filed Sep 18
-
Colette Kress CFONVDANvidia Corporation ComPlanned sale$7.6M 34,918 shares at $219.05 4.4% of stakeTraded Sep 17 Filed Sep 18
-
Dale C Fredston DirectorMCBMetropolitan Bank Holding Corp.Sale$178K 2,000 shares at $89.09 12% of stakeTraded Sep 17 Filed Sep 18
-
Lisa Roger CFOBRFHBarfresh Food Group Inc.Sale$28K 25,329 shares at $1.10 35% of stakeTraded Sep 17 Filed Sep 18
-
Yuen Wupen President, Global Bus. UnitsLITELumentum Holdings Inc.Planned sale$1.4M 1,500 shares at $903.43 1.3% of stakeTraded Sep 16–18 Filed Sep 18
-
Feng-Ming Wang CEOAMBAAmbarella, Inc.Sale$395K 6,086 shares at $64.83 0.8% of stakeTraded Sep 17 Filed Sep 18
-
Chi-Hong Ju Senior VP, Systems & GMAMBAAmbarella, Inc.Sale$130K 2,009 shares at $64.83 1.3% of stakeTraded Sep 17 Filed Sep 18
-
Chan W Lee Chief Operations OfficerAMBAAmbarella, Inc.Sale$188K 2,893 shares at $64.83 1.8% of stakeTraded Sep 17 Filed Sep 18
-
John Alexander Young CFOAMBAAmbarella, Inc.Sale$203K 3,126 shares at $64.83 2.8% of stakeTraded Sep 17 Filed Sep 18
-
Dietmar Ostermann DirectorXOSXos, Inc.Sale$13K 5,000 shares at $2.55 5.5% of stakeTraded Sep 16–17 Filed Sep 18
-
Kumar Budur Chief Medical OfficerHRMYHarmony Biosciences Holdings, Inc.Planned sale$1.7M 38,452 shares at $43.05 75% of stakeTraded Sep 16–18 Filed Sep 18
-
Leonard M Tannenbaum DirectorAFCGAdvanced Flower Capital Inc.Buy$88K 25,000 shares at $3.50 +0.4% to stakeTraded Sep 17 Filed Sep 18
-
Masatoshi Koide Pres. and Rep. Director, ALIJAFLAflac IncorporatedSale$1.6M 13,201 shares at $118.01 15% of stakeTraded Sep 16 Filed Sep 18
-
Martha Cummings DirectorMQMarqeta, Inc.Planned sale$11K 713 shares at $16.01 6.2% of stakeTraded Sep 16 Filed Sep 18
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.2M 64,000 shares at $97.49 12% of stakeTraded Sep 17–18 Filed Sep 18
-
Robert Robotti DirectorTDWTidewater Inc.Sale$925K 10,300 shares at $89.85 0.5% of stakeTraded Sep 16 Filed Sep 18
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $496.06 2.8% of stakeTraded Sep 17 Filed Sep 18
-
John R. Furner CEOWMTWalmart Inc.Planned sale$1.4M 13,125 shares at $106.66 2% of stakeTraded Sep 17 Filed Sep 18
-
Paul A Mahon EVP & General CounselUTHRUnited Therapeutics CorporationPlanned sale$4.1M 8,300 shares at $497.54 16% of stakeTraded Sep 17 Filed Sep 18
-
Samak L Azar Chief Legal OfficerGFSGlobalFoundries Inc.Planned sale$15K 335 shares at $44.87 3.4% of stakeTraded Sep 17 Filed Sep 18
-
Edward Carr Chief Accounting OfficerDNTHDianthus Therapeutics, Inc.Planned sale$2M 20,000 shares at $101.38 100% of stakeTraded Sep 17 Filed Sep 18
-
Christopher James Nicholas Executive Vice PresidentWMTWalmart Inc.Planned sale$309K 2,900 shares at $106.65 0.5% of stakeTraded Sep 17 Filed Sep 18
-
Sl Spv-2, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$26.7M 46,994 shares at $567.88 34% of stakeTraded Sep 16 Filed Sep 18
-
Troy C. Schrenk Chief Commercial OfficerTHTarget Hospitality Corp.Buy$125K 5,907 shares at $21.16 +2.8% to stakeTraded Sep 18 Filed Sep 18
-
Silver Lake Partners IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$32.3M 56,794 shares at $567.89Traded Sep 16 Filed Sep 18
-
Silver Lake Technology Investors IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$599K 1,054 shares at $567.88 100% of stakeTraded Sep 16 Filed Sep 18
-
Joseph H Capper DirectorTELATELA Bio, Inc.Buy$89K 75,000 shares at $1.18 +72% to stakeTraded Sep 16–17 Filed Sep 18
-
Silver Lake Technology Investors V, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$270K 475 shares at $567.89 100% of stakeTraded Sep 16 Filed Sep 18
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$7.8M 500,000 shares at $15.55 6.2% of stakeTraded Sep 16–17 Filed Sep 18
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.